Status:
RECRUITING
Predictors of Failed Thrombolysis in Acute Myocardial Infarction
Lead Sponsor:
Oslo University Hospital
Conditions:
STEMI - ST Elevation Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational study is to assess why thrombolytic treatment with tissue-plasminogen activator (t-PA) fails in patients with acute ST-segment elevation myocardial infarction (STEMI)...
Detailed Description
This study aims to explore why thrombolytic treatment with tissue-plasminogen activator (t-PA) fails in up to 50 % of pasients with acute ST-segment elevation myocardial infarction (STEMI). This is im...
Eligibility Criteria
Inclusion
- STEMI patients \> 18 years given prehospital thrombolysis.
Exclusion
- None.
Key Trial Info
Start Date :
April 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 3 2035
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05347732
Start Date
April 25 2022
End Date
January 3 2035
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway